MAA
AMED

Managed Account Advisors’s Amedisys AMED Stock Holding History

Managed Account Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-11,118
Closed -$129K – 2501
2013
Q2 		$129K Buy
+11,118
New +$127K ﹤0.01% 2204

Other funds holding AMED

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCA
KKR Credit Advisors San Francisco, California $796M AUM
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Managed Account Advisors's AMED Position: Q3 2013 in Review

Managed Account Advisors sold out of Amedisys (AMED) in Q3 2013, closing a stake of 11,118 shares — an estimated $129K sold.

Managed Account Advisors first reported a position in AMED in Q2 2013 and held it in 1 quarter. The position peaked at $129K in Q2 2013. 130 funds tracked by Wall St. Rank hold AMED as of Q3 2013.

  • Managed Account Advisors reported no remaining Amedisys position as of Q3 2013 after selling out during the quarter.
  • Managed Account Advisors sold 11,118 Amedisys shares in Q3 2013, an estimated $129K.
  • Managed Account Advisors first reported a position in Amedisys in Q2 2013 and held it in 1 quarter.
  • Managed Account Advisors's Amedisys position peaked at $129K in Q2 2013.
  • 130 funds tracked by Wall St. Rank held Amedisys as of Q3 2013.

Based on Managed Account Advisors's 13F filing for Q3 2013, filed 5 Nov 2013.